Visium Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Visium Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,187,013	Closed	-$24.8M	–	609
2016 Q1	$24.8M	Buy	1,187,013 +557,013	+88%	+$9.93M	0.42%	51
2015 Q4	$17M	Hold	630,000	–	–	0.26%	87
2015 Q3	$17.5M	Buy	630,000 +18,900	+3%	+$596K	0.24%	86
2015 Q2	$15M	Sell	611,100 -44,700	-7%	-$921K	0.21%	93
2015 Q1	$12M	Buy	655,800 +80,800	+14%	+$1.64M	0.18%	116
2014 Q4	$10.6M	Hold	575,000	–	–	0.15%	123
2014 Q3	$5.53M	Buy	+575,000	New	+$5.72M	0.08%	255

Other funds holding LJPC

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Visium Asset Management's LJPC Position: Q2 2016 in Review

Visium Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2016, closing a stake of 1,187,013 shares — an estimated $24.8M sold.

Visium Asset Management first reported a position in LJPC in Q3 2014 and held it in 7 quarters. The position peaked at $24.8M in Q1 2016. 73 funds tracked by Wall St. Rank hold LJPC as of Q2 2016.

Visium Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q2 2016 after selling out during the quarter.
Visium Asset Management sold 1,187,013 La Jolla Pharmaceutical Company shares in Q2 2016, an estimated $24.8M.
Visium Asset Management first reported a position in La Jolla Pharmaceutical Company in Q3 2014 and held it in 7 quarters.
Visium Asset Management's La Jolla Pharmaceutical Company position peaked at $24.8M in Q1 2016.
73 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2016.

Based on Visium Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.